|
|
Atlas Genetics
Atlas Genetics has developed a novel system for simple and ultra-rapid diagnosis of infectious diseases and will launch a 20 minute Chlamydia molecular test in 2011. This is the first of a panel of products for sexually transmitted diseases.
-
Axess Vision Technology
Axess Vision Technology develops novel single-use, sterile, video-endoscopes for medical applications.
-
Axial Biotech
Focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.
-
CeQur, Ltd.
CeQur's produces a small, wearable insulin device that delivers basal and bolus doses subcutaneously. It enables patients to easily comply with insulin regimens, including intensive insulin therapy.
-
Cytolon AG
Modern, sophisticated system to insure a proper blood match is obtained and the patient gets the correct cord blood unit in a timely manner.
-
Endo Tools Therapeutics S.A.
Endo Tools Therapeutics (ETT) is a Belgium medical device company focusing on the development of flexible endoscopic therapeutic tools for gastroenterologist.
-
Interface Biologics
Develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices, focusing on anti-thrombogenic devices that reduce thrombosis without the need for heparin and programmable combination drug delivery devices.
-
Medical Device Works
The only set of catheters for percutaneous isolation of an organ (liver) and local delivery of (any) high dosage chemotherapy for treatment of organ cancer.
-
Miracor Medical Systems GmbH
Develops Pressure-controlled Intermittent Coronary Sinus Occlusion technology for acute coronary syndrome and heart failure patients. With an extensive patent portfolio, Miracor will start its commercialization in Europe.
-
Neuravi Ltd.
Neuravi is a start up medical device company focused on the treatment of acute ischemic stroke.
-
NonWoTecc Medical
Develops and manufactures novel bio-mimetic prosthetic vascular prostheses. Due to their matrix-like design and biomechanical properties they are transformed in the body into bio-artificial arteries which resemble ”healthy” arteries in form and function.
-
Paieon Inc.
Paieon is a medical imaging company pioneering in the Cardiac field of Real-Time Device Navigation. Paieon's mission is to integrate between Imaging and Devices in complicated clinical scenarios such as TAVI and other.
-
Photo Dynamic Therapy
Non-invasive, safe and effective PHOTONIC TUMOR THERAPY as CE-certified clinical full service for patients’ unmet needs.
-
Pnn Medical A/S
The core business lies in medical devices for Minimally Invasive Treatment (MIT) methods for patients suffering from Dysfunctional Uterine Bleeding (DUB) as well as Urinary Tract Obstruction or prostate enlargement (BPH).
-
PrecisionLens
An intraocular lens customized to the patient’s vision needs and adjustable throughout the patient’s life for greater quality of vision.
-
RepRegen
Repregen™ is a London-based medical device company that uses patented repair and regeneration technology platforms designed to mend and regrow hard-tissue such as bone and soft-tissue such as cartilage.
-
SpineGuard, Inc.
SpineGuard’s mission is to make spine surgery safer and its primary goal to establish PediGuard as the standard of care for safer pedicle screw placement.
-
Surgica Robotica
Surgica Robotica is taking to market the technology that NASA developed to operate on astronauts in spacecrafts. Our solutions comprise advanced navigation tools and force feedback. The physical configuration is very light and compact, and thus easily adaptable to any type of surgical practice.
-
ThermopeutiX, Inc.
THERMOPEUTIX, INC has developed a proprietary catheter system/ treatment for ischemic brain injury. Primary markets are cardiac arrest, acute stroke and trauma.
-
Vivostat A/S
Vivostat A/S provides surgeons with the best possible tool to close surgical wounds and reduce the risk of infection via a safe sealant with a shorter time to haemostasis, a better impact on tissue, better elasticity, better accuracy of application, and no blockage of the pen.
-
Brochure Download
Get event information in a convenient PDF format.
-
IN3 West 2010
Proceedings Book
Get event information in a convenient PDF format.
-
IN3 West 2010
Audio Session
Listen to key plenary session topics.
-
IN3 West 2010
Session Slides
View Investor Day VC presentations.
-
IN3 Europe 2009
Audio Session
Listen to key plenary session topics.
-
IN3 Summit 2009
Audio Session
Listen to key plenary session topics.
-
IN3 Europe Video
Get 'behind the scenes' info on this event.
-
IN3 East Video
Get 'behind the scenes' info on this event.
-
June 9-11, 2010
The Westin Copley Place
Boston, MA - USA
www.IN3East.com
-
October 27-29, 2010
San Francisco, CA - USA
| IN3 Investor Day - April 28 |
IN3 Main Event - April 29-30 |
| Investor Day is a must-attend if you are interested in what investment leaders in the industry are thinking, doing, and planning. Noteworthy venture capitalists and corporate acquirers address what interests them most in innovative technologies, therapeutic areas, products, and geographic markets. They will also discuss partnering opportunities, how to maximize visibility in front of large company investors, and the role of M&A. |
The Main Event is designed for those in the business development and/or financial community who are interested in investment or partnering opportunities with medtech innovators. Medtech innovators give 10-minute presentations on their latest medical device innovations within a wide range of high-growth markets. In between presentation blocks, enjoy dedicated break-out sessions for one-on-one meetings, and networking. |
"It is shocking how many device companies make it into our conference room and really do not know much about our firm... Research about the investor is absolutely essential to be successful... [Do your research.] So few people actually do the research."
- Jim Scopa, Managing Director, MPM Capital
- Nearly 30 presentations by medical technology innovators with the most desired technologies.
- 20+ finance presentations and perspectives by some of the industry's biggest players.
- Over two dozen networking opportunities.
- Partnering Software to identify attendees and plan private, 1-on-1 meetings in advance – all without schedule overlap or program interrupt.
- Multiple keynote plenary panels on the latest 'deals' case studies, device investing, M&A, health reform, clinicians, and more!
- Access to current and future news on investing and partnering, as driven by Elsevier Business Intelligence researchers, analysts, and authors.
Over 1,500 emerging medical technology company presenters and more than 8,000 attendees have participated at IN3 events over the past nine years. We are very proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events. Click Here for success stories and testimonials from our past presenters and attendees.
Click Title for More Info
| Why Use Windhover Conferences Partnering Software? |
- • Identify attendees to choose potential partners.
- • Search database of partnering/investing opportunities(including deal history and related articles).
- • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
- • Showcase your company's innovative technology and investment/partnering interests.
|
For more information, please contact:
Kristy Kennedy at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.
| Important Deadlines |
Save $100 before: |
03/28/2010 |
| Last Chance for Discounted Rooms (may sell out earlier) |
04/15/2010 |
| Partnering Opens (start scheduling meetings) |
04/07/2010 |
| Innovator Company Profile Due |
04/07/2010 |
Click Here to view full pricing schedule.
Who Attends
- • Presidents, CEOs, CTOs, COOs
- • Founders, Chairpersons
- • Venture Partners
- • Managing Directors
- • VPs/Directors of Strategic Planning, Business Development, Marketing, New Technology, Acquisitions, R&D, & Sales
- • Senior Investment
- • Analysts/Principals/Directors
- • Established device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
- • VCs and investment bankers.
- • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.
Benefits of Attending
Potential acquirers/funding partners can meet and screen over 50 hand-selected, first-rate investment possibilities in just two well-orchestrated days, via focused presentations covering widely varied technologies, stages of development and testing, potential markets, management teams, regulatory timeline, patent protection, competitive strategy, funding desired, and much more... Including private break-out sessions and networking events.
Medical device start-ups face intense competition for a finite amount of available capital funding. This makes IN3 events the ideal setting for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world.
All attendees will gain a keen under-standing (in a short timeframe) of the emerging medical technologies that are on track to make a distinct impact on the intensely-competitive device industry.
Advisory Board
- Annette Campbell-White
Senior Managing Member
MedVenture Associates
- Michael Carusi
General Partner
Advanced Technology Ventures
- Luke Evnin
General Partner
MPM Capital
- Richard M. Ferrari
Managing Director
DeNovo Ventures
- William T. Harrington
Partner
Three Arch Partners
- Ross A. Jaffe
Managing Director
Versant Ventures
- Josh Makower
Venture Partner
NEA
- John Maroney
General Partner
Delphi Ventures
- Allan May
Chairman, Founder
Life Science Angels
Managing Director
Emergent Medical Partner
- David Milne
Managing Partner
SV Life Science Advisers
- Trevor J. Moody
Partner
Frazier Healthcare Ventures
- Jesse I Treu
Partner
Domain Associates
|
|